Next Article in Journal
Porophyllum Genus Compounds and Pharmacological Activities: A Review
Previous Article in Journal
Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as Potential Drugs for Type 2 Diabetes Mellitus—A Systematic Review of Clinical and In Vivo Preclinical Studies
Open AccessReview

Sedating Mechanically Ventilated COVID-19 Patients with Volatile Anesthetics: Insights on the Last-Minute Potential Weapons

1
Department of Anesthesia and Intensive Care, School of Medicine, The University of Jordan, Amman 11942, Jordan
2
Department of Internship Program, School of Medicine, The University of Jordan, Amman 11942, Jordan
3
Department of Anesthesia and Intensive Care, King Hussein Cancer Center, Amman 11942, Jordan
4
Department of Emergency Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan
5
Department of Anesthesia and Intensive Care, Alabdali Clemenceau Hospital, Amman 11190, Jordan
*
Authors to whom correspondence should be addressed.
Sci. Pharm. 2021, 89(1), 6; https://doi.org/10.3390/scipharm89010006
Received: 9 December 2020 / Revised: 26 December 2020 / Accepted: 5 January 2021 / Published: 8 January 2021
Coronavirus Disease 2019 (COVID-19) has spread globally with the number of cases exceeding seventy million. Although trials on potential treatments of COVID-19 Acute Respiratory Distress Syndrome (ARDS) are promising, the introduction of an effective therapeutic intervention seems elusive. In this review, we explored the potential therapeutic role of volatile anesthetics during mechanical ventilation in the late stages of the disease. COVID-19 is thought to hit the human body via five major mechanisms: direct viral damage, immune overactivation, capillary thrombosis, loss of alveolar capillary membrane integrity, and decreased tissue oxygenation. The overproduction of pro-inflammatory cytokines will eventually lead to the accumulation of inflammatory cells in the lungs, which will lead to ARDS requiring mechanical ventilation. Respiratory failure resulting from ARDS is thought to be the most common cause of death in COVID-19. The literature suggests that these effects could be directly countered by using volatile anesthetics for sedation. These agents possess multiple properties that affect viral replication, immunity, and coagulation. They also have proven benefits at the molecular, cellular, and tissue levels. Based on the comprehensive understanding of the literature, short-term sedation with volatile anesthetics may be beneficial in severe stages of COVID-19 ARDS and trials to study their effects should be encouraged. View Full-Text
Keywords: sedation; COVID-19; ARDS; respiratory failure; volatile anesthetics; mechanical ventilation sedation; COVID-19; ARDS; respiratory failure; volatile anesthetics; mechanical ventilation
Show Figures

Figure 1

MDPI and ACS Style

Suleiman, A.; Qaswal, A.B.; Alnouti, M.; Yousef, M.; Suleiman, B.; Jarbeh, M.E.; Alshawabkeh, G.; Bsisu, I.; Santarisi, A.; Ababneh, M. Sedating Mechanically Ventilated COVID-19 Patients with Volatile Anesthetics: Insights on the Last-Minute Potential Weapons. Sci. Pharm. 2021, 89, 6.

AMA Style

Suleiman A, Qaswal AB, Alnouti M, Yousef M, Suleiman B, Jarbeh ME, Alshawabkeh G, Bsisu I, Santarisi A, Ababneh M. Sedating Mechanically Ventilated COVID-19 Patients with Volatile Anesthetics: Insights on the Last-Minute Potential Weapons. Scientia Pharmaceutica. 2021; 89(1):6.

Chicago/Turabian Style

Suleiman, Aiman; Qaswal, Abdallah B.; Alnouti, Mazen; Yousef, Moh’d; Suleiman, Bayan; Jarbeh, Mohammad E.; Alshawabkeh, Ghadeer; Bsisu, Isam; Santarisi, Abeer; Ababneh, Muaweih. 2021. "Sedating Mechanically Ventilated COVID-19 Patients with Volatile Anesthetics: Insights on the Last-Minute Potential Weapons" Sci. Pharm. 89, no. 1: 6.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop